Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹1,398 Cr₹729 Cr₹582 Cr₹513 Cr₹359 Cr

What is the latest Total Current Liabilities ratio of GLAND PHARMA ?

The latest Total Current Liabilities ratio of GLAND PHARMA is ₹1,398 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹1,398 Cr
Mar2023₹729 Cr
Mar2022₹582 Cr
Mar2021₹513 Cr
Mar2020₹359 Cr

How is Total Current Liabilities of GLAND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2024 ₹1,398 Cr
91.78
Mar2023 ₹729 Cr
25.28
Mar2022 ₹582 Cr
13.56
Mar2021 ₹513 Cr
42.76
Mar2020 ₹359 Cr -

Compare Total Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,973.2 Cr 5.9% 17.1% -2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.9%

17.1%

-2.2%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses